These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


722 related items for PubMed ID: 11197587

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A.
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [Abstract] [Full Text] [Related]

  • 23. Neuraminidase inhibitors in patients with underlying airways disease.
    Williamson JC, Pegram PS.
    Am J Respir Med; 2002 Jan; 1(2):85-90. PubMed ID: 14720062
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
    Kaji M.
    Nihon Rinsho; 2003 Nov; 61(11):1975-9. PubMed ID: 14619441
    [Abstract] [Full Text] [Related]

  • 26. Zanamivir: an influenza virus neuraminidase inhibitor.
    Colman PM.
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):191-9. PubMed ID: 15918777
    [Abstract] [Full Text] [Related]

  • 27. Updated treatment for influenza A and B.
    Montalto NJ, Gum KD, Ashley JV.
    Am Fam Physician; 2000 Dec 01; 62(11):2467-76. PubMed ID: 11130232
    [Abstract] [Full Text] [Related]

  • 28. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
    Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK.
    JAMA; 2000 Dec 01; 275(4):295-9. PubMed ID: 8544269
    [Abstract] [Full Text] [Related]

  • 29. New approaches to influenza chemotherapy. Neuraminidase inhibitors.
    Calfee DP, Hayden FG.
    Drugs; 1998 Oct 01; 56(4):537-53. PubMed ID: 9806102
    [Abstract] [Full Text] [Related]

  • 30. Influenza prevention 2002-2003.
    Med Lett Drugs Ther; 2002 Sep 02; 44(1138):75-6. PubMed ID: 12205427
    [No Abstract] [Full Text] [Related]

  • 31. Effect of zanamivir on duration and resolution of influenza symptoms.
    Monto AS, Moult AB, Sharp SJ.
    Clin Ther; 2000 Nov 02; 22(11):1294-305. PubMed ID: 11117654
    [Abstract] [Full Text] [Related]

  • 32. Two neuraminidase inhibitors for treatment of influenza.
    Med Lett Drugs Ther; 1999 Oct 08; 41(1063):91-3. PubMed ID: 10535051
    [No Abstract] [Full Text] [Related]

  • 33. Neuraminidase inhibitors and relief of influenza symptoms.
    Lemon M, Meade F.
    S D J Med; 2000 Mar 08; 53(3):99-100. PubMed ID: 10745653
    [No Abstract] [Full Text] [Related]

  • 34. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec 12; 352(9144):1877-81. PubMed ID: 9863784
    [Abstract] [Full Text] [Related]

  • 35. [Critical review of anti-influenza drugs].
    van Loon FP, Voordouw AC, Simonian S, Koopmans PP.
    Ned Tijdschr Geneeskd; 2000 Jan 22; 144(4):165-7. PubMed ID: 10668542
    [Abstract] [Full Text] [Related]

  • 36. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson T, Demicheli V, Deeks J, Rivetti D.
    Cochrane Database Syst Rev; 2000 Jan 22; (2):CD001265. PubMed ID: 10796625
    [Abstract] [Full Text] [Related]

  • 37. [Zanamivir, oseltamivir].
    Kashiwagi S.
    Nihon Rinsho; 2004 Dec 22; 62 Suppl 12():445-7. PubMed ID: 15658359
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS, Fleming DM, Henry D, de Groot R, Makela M, Klein T, Elliott M, Keene ON, Man CY.
    J Infect Dis; 1999 Aug 22; 180(2):254-61. PubMed ID: 10395837
    [Abstract] [Full Text] [Related]

  • 39. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK, Nguyen-Van-Tam JS.
    N Engl J Med; 2006 Mar 30; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract] [Full Text] [Related]

  • 40. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P.
    MMW Fortschr Med; 2002 Nov 28; 144(48):18. PubMed ID: 12532540
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 37.